FDA Grants AP Status for Verapamil Hydrochloride ANDA211035
The FDA has granted Abbreviated Approval (AP) status to Somerset for their ANDA211035 application for Verapamil Hydrochloride.
Asset / Drug
Drug and asset intelligence for Somerset with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.